Orlucent Demonstrates Accurate, Non-Invasive Detection in vivo of Melanoma-Related Activity Using First-in-Kind Handheld Mole Imaging System

/PRNewswire/ -- In a first-in-human study, researchers at Orlucent, Inc. have demonstrated the viability of a novel handheld point-of-care molecular Skin...

Related Keywords

Oregon ,United States ,Sancy Leachman ,Jeff Christensen ,Catherine Shachaf ,Melanoma Research ,Melanoma Research Program ,Oregon Health Science University Knight Cancer Institute ,Orlucent Inc ,A Tool For Evaluating Early Melanoma Development ,Skin Fluorescence Imaging ,Pigment Cell ,Breakthrough Device ,Skin Fluorescence Imaging System ,Oregon Health ,Science University Knight Cancer Institute ,Evaluating Early Melanoma Development ,Orlucent Imaging System ,Orlucent ,Nc ,